tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Revenue

Compare
0 Followers

Oncolys BioPharma, Inc. Revenue

Oncolys BioPharma, Inc. had a revenue of 28.55M in the quarter ending Jun 30, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 28.55M, Increased -9.04%. In the fiscal year ending Dec 31, 2024, Oncolys BioPharma, Inc. had annual revenue of 31.38M with -50.21% growth.
Revenue (ttm)
28.55M
Revenue Growth
-9.04%
P/S Ratio
1415.96
Revenue/Employee
¥784,600
Employees
40
Market Cap
¥44.44B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
31.38M-31.65M+49.79%
Dec 31, 2023
63.04M-913.14M+6.46%
Dec 31, 2022
976.18M333.69M+151.94%
Dec 31, 2021
642.49M328.31M+204.50%
Dec 31, 2020
314.18M-989.66M+24.10%
Dec 31, 2019
1.30B1.14B+773.57%
Dec 31, 2018
168.55M-60.59M+73.56%
Dec 31, 2017
229.14M50.83M+128.50%
Dec 31, 2016
178.31M